<SEC-DOCUMENT>0000939798-17-000098-index.html : 20171201 <SEC-HEADER>0000939798-17-000098.hdr.sgml : 20171201 <ACCEPTANCE-DATETIME>20171201170623 ACCESSION NUMBER: 0000939798-17-000098 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170901 FILED AS OF DATE: 20171201 DATE AS OF CHANGE: 20171201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silverman Mark J CENTRAL INDEX KEY: 0001721628 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 171234822 MAIL ADDRESS: STREET 1: 224 22ND ST. CITY: SANTA MONICA STATE: CA ZIP: 90402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1825 K STREET STREET 2: SUITE 510 CITY: WASHINGTON, D.C. STATE: DC ZIP: 33602 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 1825 K STREET STREET 2: SUITE 510 CITY: WASHINGTON, D.C. STATE: DC ZIP: 33602 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 </SEC-HEADER> <DOCUMENT> <TYPE>3 <SEQUENCE>1 <FILENAME>primary_doc.xml <DESCRIPTION>PRIMARY DOCUMENT <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> </SEC-DOCUMENT>